Cite
HARVARD Citation
Palshof, J. et al. (n.d.). 433PAn open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors. Annals of oncology. p. . [Online].